Bicalutamide Granules

(Product under development)
Bicalutamide GranulesBicalutamide is an oral non-steroidal anti-androgen used in the treatment of prostate cancer and hirsutism.

It was first launched in 1995 as a combination treatment (with surgical or medical castration) for advanced prostate cancer and subsequently launched as monotherapy for the treatment of earlier stages of the disease.

It is recommended 50 mg once daily in combination with a luteinizing hormone-releasing hormone analogue or surgical castration.

Available Form:
Bicalutamide Granules
Bicalutamide Pellets

Umang Pharmatech equipments used for production of Bicalutamide Granules:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.


Bicalutamide Granules
Systematic (IUPAC) Name
Bicalutamide Granules
Identifiers
Bicalutamide Granules
Chemical data
N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide
CAS number : 90357-06-5
ATC code : L02BB03
PubChem : CID 2375
DrugBank : APRD00042
ChemSpider : 2284
UNII : A0Z3NAU9DP
ChEMBL : CHEMBL63560
Formula : C18H14F4N2O4S
Mol. mass : 430.373 g/mol


* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech
TESTIMONIAL